A previous study has shown that Met protein is overexpressed in esophageal adenocarcinoma (EA) surgical specimens and EA cell lines, while Met dysregulation can occur early in the progression from Barrett’s dysplasia to adenocarcinoma [16], [17]. This evidence concerns the gene MET and adenocarcinoma.